WIP
ABBV icon

WealthCare Investment Partners’s AbbVie ABBV Stock Holding History

WealthCare Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
2,012
+1,007
+100% +$223K 0.12% 131
2025
Q4 		$230K Buy
1,005
+40
+4% +$9.11K 0.07% 171
2025
Q3 		$236K Buy
+965
New +$197K 0.08% 158

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WealthCare Investment Partners's ABBV Position: Q1 2026 in Review

WealthCare Investment Partners increased its AbbVie (ABBV) stake by 100% in Q1 2026, buying an estimated $223K and bringing the position to 2,012 shares worth $417K. The position accounts for 0.12% of the portfolio, ranked #131.

WealthCare Investment Partners first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • WealthCare Investment Partners held 2,012 shares of AbbVie worth $417K as of Q1 2026.
  • WealthCare Investment Partners bought 1,007 AbbVie shares in Q1 2026, an estimated $223K.
  • AbbVie made up 0.12% of WealthCare Investment Partners's portfolio in Q1 2026, its #131 holding.
  • WealthCare Investment Partners first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on WealthCare Investment Partners's 13F filing for Q1 2026, filed 9 Apr 2026.